Reviewing the Year-end MDA... "On October 13, 2017, two subsidiaries of the Company, Concordia Pharmaceuticals (US), Inc. and Pinnacle Biologics, Inc. entered into an agreement with the Company’s Chief Executive Officer to guaranty payments due under the officer’s employment agreement."
This is how bad it has gotten. Oberman is afraid that the Company will not have enough money even to pay his salary!
"Significant costs incurred during 2017 include $22,862 of costs associated with the Company's realignment of its capital structure"
What are these professionals doing? They alone could bankrupt the company! The figure is probably $4,000,000 or more higher by now. The run rate is at least $3,000,000 a month.
It is difficult to find anything positive in the document. The whole thing is a major scandal.